Pancreatitis, obstruction, gallbladder: three things nausea can be
Rapid weight loss by any means raises gallstone risk. Separating that from a direct drug effect requires a comparator, and the trials have one.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 24 of 68 of this archive, newest first.
Rapid weight loss by any means raises gallstone risk. Separating that from a direct drug effect requires a comparator, and the trials have one.
What was withdrawn, from whom, after how long, and what was measured afterwards.
The evidence base is thin and the document says so, which is to its credit.
Reported from the sessions, and from the two hours afterwards.
The route did not close because of a rule about peptides.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The header identifies the batch, the table records the tests, and the footer says who is answerable. Two of the three are usually incomplete.
The dose-response curve in this class flattens near its top. That has direct consequences for whether the final rung is worth climbing.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Reported from the analysis, not from a warning notice.
A proper account of an operation that existed, and of what closing it cost.
Every certificate circulating in this market answers a question about molecules. Almost none answers a question about organisms, pyrogens, or the integrity of the seal.
The header identifies the batch, the table records the tests, and the footer says who is answerable. Two of the three are usually incomplete.
What a slow reduction could plausibly buy, and what it certainly cannot prevent.
Follow the resin, not the catalogue.
Efficacy was never the question in this appraisal. Duration of treatment was.
A proper account of an operation that existed, and of what closing it cost.
The evidence base is thin and the document says so, which is to its credit.
The receptor is expressed in more tissues than the popular account allows, and that is the whole story.
Efficacy was never the question in this appraisal. Duration of treatment was.
Follow the resin, not the catalogue.
A proper account of an operation that existed, and of what closing it cost.
The route did not close because of a rule about peptides.
Two sources of noise sit under every number: how reproducible the assay is, and how much the analyte varies within the same person on the same day.
Trial discontinuation figures are a floor, not an estimate: trial populations are supported in ways ordinary patients are not.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The route did not close because of a rule about peptides.
Reported from the sessions, and from the two hours afterwards.
A survey of what the meta-analyses support, with the populations named.
The Journal does not treat a badge as evidence and states so wherever it reports one.